Kay Hagan actually said...

It certainly seems like something that we need to work together on, because with these huge numbers of vacancies it's certainly posing problems and risks in this area.

Context

Hagan emphasizes the need for collaboration to address staffing issues.

01/26/2009

https://www.congress.gov...

More Kay Hagan Quotes

One complaint that I continue to hear from constituent companies is that the FDA's medical device review process is unpredictable and incons...
11/14/2011
Moreover, the agency may not ask for scientific evidence, greater than the 'least burdensome,' to answer the question.
11/14/2011
I think that's critical.
11/14/2011
If I reference the IOM report again here, in the United States, use of clinical data in the regulatory review process is defined by the enab...
11/14/2011

View All Kay Hagan Quotes